✦ LIBER ✦

Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell linesin vitroand inscidmice

✍ Scribed by Mitchell R Smith; Indira Joshi; Fang Jin; Coleman Obasaju

Book ID: 115010623
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 554 KB
Volume: 5
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-5-103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of B-cell non-Hodgkin's lympho

Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab

✍ Stefano Sacchi; Massimo Federico; Giuseppe Dastoli; Claudia Fiorani; Giovanni Vi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Rituximab is a chimeric anti CD-20 monoclonal antibody containing human IgG1 kappa constant regions, with murine variable regions. The anti-lymphoma effects of Rituximab are probably due to complement and antibody-dependent cell-mediated cytotoxicity, and induction of apoptosis. Phase II trials have

Treatment of relapsed B-cell non-Hodgkin

Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy

✍ van der Kolk, L E; Grillo-López, A J; Baars, J W; van Oers, M H J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

Clinical trials of a mouse-human chimeri

Clinical trials of a mouse-human chimeric anti-CD20 monoclonal antibody (rituximab) for B cell non-Hodgkin's lymphoma in Japan

✍ Kensei Tobinai 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 130 KB

Use of Ibritumomab Tiuxetan Anti-CD20 Ra

Use of Ibritumomab Tiuxetan Anti-CD20 Radioimmunotherapy in a Non-Hodgkin's Lymphoma Patient Previously Treated with a Yttrium-90–Labeled Anti-CD22 Monoclonal Antibody

✍ Tsai, Donald E.; Maillard, Ivan; Schuster, Stephen J.; Nasta, Sunita D.; Porter, 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 478 KB

Lymphocyte subsets and viral load in pat

Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapy

✍ P. De Paoli; E. Vaccher; R. Tedeschi; C. Caffau; S. Zanussi; M. T. Bortolin; C. 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 136 KB

Anti-CD20 Monoclonal Antibody (Rituximab

Anti-CD20 Monoclonal Antibody (Rituximab) for Therapy of Mediastinal CD20-Positive Large B-Cell Non-Hodgkin Lymphoma with a Local Tumor Extension into the Lung of a 10-Year-Old Girl

✍ Čulić, Srdjana; Čulić, Vida; Armanda, Visnja; Kuljiš, Dubravka; Pešutić-Pisac, V 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 208 KB